Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Houma-Bayou Cane-Thibodaux, LA Metro Edition
Focus: LIFE SCI
Houma's tight labor market masks a life sciences talent desert.
4.1%
Terrebonne/Lafourche unemployment
May 2026, among Louisiana's lowest parish rates
6.69
Houma RLMA candidates per opening
1,542 postings vs 13,310 active candidates, Feb 2026
79 workers
LA generic pharma manufacturing jobs
Declining 10.4% annually statewide
$320K-$580K
VP Regulatory Affairs base pay (national)
Reflects acute national regulatory scarcity
This Month's Takeaways
Houma's labor market is tight, but not for the roles you need.
Parish-level unemployment at 4.1% and a 6.69-candidate-per-opening ratio reflect energy, healthcare, and government hiring pressure, not life sciences scarcity. Benchmarking local compensation against overall metro tightness risks mispricing specialized scientific and regulatory roles that draw from a national, not regional, candidate pool.
Louisiana's manufacturing base offers no local anchor for CMC builds.
Generic pharmaceutical manufacturing employment in Louisiana sits at just 79 workers and is shrinking 10.4% annually, confirming the state lacks the infrastructure for internal biologics or drug-product manufacturing scale-up. CDMO partnerships remain the structurally logical path for Houma-area employers weighing manufacturing headcount investment.
National regulatory affairs scarcity will hit Houma-based searches harder.
Director-level clinical-stage talent is taking 10-16 weeks to fill nationally, and VP Regulatory Affairs compensation now ranges $320K-$580K for candidates with first-in-class BLA/NDA experience. Without a regional talent base to draw from, Houma employers competing for these roles are effectively bidding in the national market with none of the local supply cushion.
Selective hiring elsewhere in biopharma doesn't mean easier sourcing here.
National layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions while 64% of biopharma organizations continue active recruiting, meaning displaced talent isn't necessarily regulatory, CMC, or clinical operations talent. Houma-area leaders should not assume September layoff headlines translate into a deeper local or remote-hire candidate pool for execution-critical roles.
Local Labor Conditions
Houma MSA unemployment held near 4.1% through spring 2026 across both Terrebonne and Lafourche parishes, among the tightest in Louisiana, while the Houma Regional Labor Market Area showed just 6.69 candidates per open job posting in its most recent read — a labor pool stretched thin before life sciences employers even enter the bidding. Offshore energy services, healthcare, and government continue to anchor local wage-setting, meaning any biotech, pharma, or device employer recruiting locally competes against sectors with established, well-funded pay structures rather than a dedicated life sciences labor pool.
Leadership & Talent Implications
Thin local candidate density and the near-absence of generic pharmaceutical manufacturing employment in Louisiana (79 workers statewide, declining) confirm that build-vs-outsource decisions in this metro tilt structurally toward CRO/CDMO partnerships rather than local hires for specialized R&D, clinical, or manufacturing roles. Any regulatory, quality, or CMC headcount leaders do try to fill locally will face national-level scarcity pricing — director-level clinical operations and CMC roles command $210K–$520K nationally — layered on top of a metro labor market with minimal benchmarking infrastructure for these functions. Consider reviewing whether critical regulatory and CMC roles are better resourced through remote or hybrid hires drawing on coastal compensation data, rather than anchoring offers to local parish wage figures that reflect energy and healthcare labor markets, not life sciences talent.
